164 related articles for article (PubMed ID: 12616334)
21. Comparison of nicotine oral soluble film and nicotine lozenge on efficacy in relief of smoking cue-provoked acute craving after a single dose of treatment in low dependence smokers.
Du D; Nides M; Borders J; Selmani A; Waverczak W
Psychopharmacology (Berl); 2014 Nov; 231(22):4383-91. PubMed ID: 24781517
[TBL] [Abstract][Full Text] [Related]
22. Abuse liability assessment of the JUUL system in four flavors relative to combustible cigarette, nicotine gum and a comparator electronic nicotine delivery system among adult smokers.
Goldenson NI; Buchhalter AR; Augustson EM; Rubinstein ML; Henningfield JE
Drug Alcohol Depend; 2020 Dec; 217():108395. PubMed ID: 33176942
[TBL] [Abstract][Full Text] [Related]
23. Pharmacodynamic and pharmacokinetic assessment of electronic cigarettes, combustible cigarettes, and nicotine gum: implications for abuse liability.
Stiles MF; Campbell LR; Graff DW; Jones BA; Fant RV; Henningfield JE
Psychopharmacology (Berl); 2017 Sep; 234(17):2643-2655. PubMed ID: 28634710
[TBL] [Abstract][Full Text] [Related]
24. Pharmacotherapy for tobacco dependence.
Fant RV; Buchhalter AR; Buchman AC; Henningfield JE
Handb Exp Pharmacol; 2009; (192):487-510. PubMed ID: 19184660
[TBL] [Abstract][Full Text] [Related]
25. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial.
Shiffman S; Ferguson SG; Strahs KR
Am J Prev Med; 2009 Feb; 36(2):96-104.e1. PubMed ID: 19135903
[TBL] [Abstract][Full Text] [Related]
26. The impact of anticipated and unanticipated smoking opportunities on cigarette smoking and nicotine lozenge responses.
Schlagintweit HE; Greer H; Good KP; Barrett SP
Drug Alcohol Depend; 2015 Feb; 147():97-102. PubMed ID: 25561388
[TBL] [Abstract][Full Text] [Related]
27. Comparative efficacy of rapid-release nicotine gum versus nicotine polacrilex gum in relieving smoking cue-provoked craving.
Niaura R; Sayette M; Shiffman S; Glover ED; Nides M; Shelanski M; Shadel W; Koslo R; Robbins B; Sorrentino J
Addiction; 2005 Nov; 100(11):1720-30. PubMed ID: 16277632
[TBL] [Abstract][Full Text] [Related]
28. Use of more nicotine lozenges leads to better success in quitting smoking.
Shiffman S
Addiction; 2007 May; 102(5):809-14. PubMed ID: 17493108
[TBL] [Abstract][Full Text] [Related]
29. Nicotine lozenges for the treatment of smokeless tobacco use.
Ebbert JO; Dale LC; Severson H; Croghan IT; Rasmussen DF; Schroeder DR; Vander Weg MW; Hurt RD
Nicotine Tob Res; 2007 Feb; 9(2):233-40. PubMed ID: 17365754
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
[TBL] [Abstract][Full Text] [Related]
31. Elimination of Cigarette Smoke-derived Acetaldehyde in Saliva by Slow-release L-Cysteine Lozenge Is a Potential New Method to Assist Smoking Cessation. A Randomised, Double-blind, Placebo-controlled Intervention.
Syrjänen K; Salminen J; Aresvuo U; Hendolin P; Paloheimo L; Eklund C; Salaspuro M; Suovaniemi O
Anticancer Res; 2016 May; 36(5):2297-306. PubMed ID: 27127136
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic characterization of three novel 4-mg nicotine lozenges
.
Sukhija M; Srivastava R; Kaushik A
Int J Clin Pharmacol Ther; 2018 Mar; 56(3):113-119. PubMed ID: 29350176
[TBL] [Abstract][Full Text] [Related]
33. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.
Le Houezec J
Int J Tuberc Lung Dis; 2003 Sep; 7(9):811-9. PubMed ID: 12971663
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell).
Dautzenberg B; Nides M; Kienzler JL; Callens A
BMC Clin Pharmacol; 2007 Oct; 7():11. PubMed ID: 17922899
[TBL] [Abstract][Full Text] [Related]
35. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
Etter JF; Schneider NG
Nicotine Tob Res; 2013 Jan; 15(1):59-68. PubMed ID: 22529220
[TBL] [Abstract][Full Text] [Related]
36. Nicotine Metabolite Ratio Is Associated With Lozenge Use But Not Quitting in Smokeless Tobacco Users.
Ebbert JO; Severson HH; Danaher BG; Benowitz NL; Schroeder DR
Nicotine Tob Res; 2016 Mar; 18(3):366-70. PubMed ID: 25977408
[TBL] [Abstract][Full Text] [Related]
37. A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction.
Thornley S; McRobbie H; Lin RB; Bullen C; Hajek P; Laugesen M; Senior H; Whittaker R
Nicotine Tob Res; 2009 Jun; 11(6):715-21. PubMed ID: 19454549
[TBL] [Abstract][Full Text] [Related]
38. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.
Hatsukami DK; Kotlyar M; Hertsgaard LA; Zhang Y; Carmella SG; Jensen JA; Allen SS; Shields PG; Murphy SE; Stepanov I; Hecht SS
Addiction; 2010 Feb; 105(2):343-55. PubMed ID: 20078491
[TBL] [Abstract][Full Text] [Related]
39. Nicotine nasal spray and vapor inhaler: abuse liability assessment.
Schuh KJ; Schuh LM; Henningfield JE; Stitzer ML
Psychopharmacology (Berl); 1997 Apr; 130(4):352-61. PubMed ID: 9160851
[TBL] [Abstract][Full Text] [Related]
40. Abuse liability assessment of the JUUL system in two nicotine concentrations compared to combustible cigarette, nicotine gum and comparator electronic nicotine delivery system.
Goldenson NI; Buchhalter AR; Augustson EM; Rubinstein ML; Van Hoof D; Henningfield JE
Drug Alcohol Depend; 2020 Dec; 217():108441. PubMed ID: 33250386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
